Inflammatory markers are associated with left ventricular hypertrophy and diastolic dysfunction in a population-based sample of elderly men and women

Journal of Human Hypertension

Volumn 27, Issue 1, 2013, Pages 13-17

  Masiha, S ^a   Sundstrom J ^a   Lind, L ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

echocardiography; inflammation; left ventricular hypertrophy

Indexed keywords

ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; L SELECTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PADGEM PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY MASS; CARDIOVASCULAR INFLAMMATION; CARDIOVASCULAR RISK; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DIASTOLIC DYSFUNCTION; DOPPLER ECHOCARDIOGRAPHY; FEMALE; GENDER; GERIATRIC PATIENT; HEART INDEX; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OBESITY; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DIASTOLE; E-SELECTIN; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; MALE; PROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84870821776     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2011.113     Document Type: Article

References (31)

1. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Engl J Med 1990; 322(22): 1561-1566.
2. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study. Ann Intern Med 1989; 110(2): 101-107.
3. Casale PN, Devereux RB, Milner M, Zullo G, Harshfield GA, Pickering TG et al. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986; 105(2): 173-178.
4. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114(5): 345-352.
5. Kuwahara F, Kai H, Tokuda K, Kai M, Takeshita A, Egashira K et al. Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats. Circulation 2002; 106: 130-135.
6. Kuwahara K, Kai H, Tokuda K, Niiyama H, Tahara N, Kusaba K et al. Roles of intercellular adhesion molecule-1 in hypertensive cardiac remodeling. Hypertension 2003; 41: 819-823.
7. Suresh PS, Kenichi W, Meilei MA, Hitoshi T, Makoto K, Yoshifusa A. Involvement of mast cells in the development of fibrosis in rats with postmyocarditis dilated cardiomyopathy. Biol Pharm Bull 2005; 28(11): 2128-2132.
8. Bozkurt B, Kribbs SB, Clubb Jr FJ, Michael LH, Didenko VV, Hornsby PJ et al. Pathophysiologically relevant concentrations of tumor necrosis factor-a promote progressive left ventricular dysfunction and remodeling in rats. Circulation 1998; 97(14): 1382-1391.
9. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973-979.
10. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836-843.
11. Ridker PM, Rifai N, Clearfield M, Downs JR, Weis SE, Miles JS, et al., Air Force/Texas Coronary Atherosclerosis Prevention Study Investigators. Prevention study investigators. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 2001; 344: 1959-1965.
12. Ridker PM, Rifai N, Rose L, Buring JE, Cook JR. Comparison of C-reactive protein and low-density lipoprotein cholesterol in the prediction of first cardiovascular events. N Engl J Med 2002; 347: 1557-1565.
13. Tracy RP, Lemaitre RN, Psaty BM, Ives DG, Evans RW, Cushman M et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol 1997; 17: 1121-1127.
14. Koenig W, Sund M, Froelich M, Fischer HG, Lö wel H, Dö ring A et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring trends and determinants in cardiovascular disease) Augsberg Cohort Study, 1984-1992. Circulation 1999; 99: 237-242.
15. Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein (a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 2001; 285: 2481-2485.
16. Danesh J, Whincup P, Wlaker M, Lennon L, Thomson A, Appleby P et al. Low grade inflammation and coronary heart disease: prospective study and updated metaanalyses. BMJ 2000; 321: 199-204.
17. Bo S, Mandrile C, Milanesio N, Pagani A, Gentile L, Gambino R et al. Is left ventricular hypertrophy a low-level inflammatory state? A population-based cohort study. Nutr Metab Cardiovasc Dis 2011 (e-pub ahead of print March 2011).
18. Yuko TK, Kazuo K, Rie T, Katsushi M. Vascular cell adhesion molecule-1 as a biochemical marker of left ventricular mass in the patients with hypertension. Am J Hypertens 2001; 14: 868-872.
19. Malmqvist K, Wallén HN, Held C, Kahan T. Soluble cell adhesion molecules in,hypertensive concentric left ventricular hypertrophy. J Hypertens 2002; 20: 1563-1569.
20. Palmieri V, Tracy RP, Roman MJ, Liu JE, Best LG, Bella JN et al. Strong heart study. Relation of left ventricular hypertrophy to inflammation and albuminuria in adults with type 2 diabetes: the strong heart study. Diabetes Care 2003; 26(10): 2764-2769.
21. Erten Y, Tulmac M, Derici U, Pasaoglu H, Altok RK, Bali M et al. An association between inflammatory state and left ventricular hypertrophy in hemodialysis patients. Ren Fail 2005; 27(5): 581-589.
22. Lind L, Fors N, Hall J, Marttala K, Stenborg A. A comparison of three different methods to evaluate endothelium-dependent vasodilation in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Arterioscler Thromb Vasc Biol 2005; 25: 2368-2375.
23. Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992; 19: 1559-1560.
24. Levine B, Kalman J, Mayer L, Fillit HM, Packer M, Demetris AJ. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990; 323: 236-241.
25. Kubota T, Miyagishima M, Alvarez RJ, Kormos R, Rosenblum WD, Demetris AJ et al. Expression of proinflammatory cytokines in the failing human heart: comparison of recent-onset and end-stage congestive heart failure. J Heart Lung Transplant 2000; 19: 819-824.
26. Kubota T, McTiernan CF, Frye CS, Slawson SE, Lemster BH, Koretsky AP et al. Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circ Res 1997; 81: 627-635.
27. Wang CH, Li SH, Weisel RD, Fedak PW, Dumont AS, Szmitko P, et al. Mickle DA, Verma S C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation 2003; 107: 1783-1790.
28. Xing D, Hage FG, Chen YF, McCrory MA, Feng W, Skibinski GA, et al. Oparil S, Szalai AJ Exaggerated neointima formation in human C-reactive protein transgenic mice is IgG Fc receptor type I (Fc gamma RI)-dependent. Am J Pathol 2008; 172: 22-30.
29. Vongpatanasin W, Thomas GD, Schwartz R, Cassis LA, Osborne-Lawrence S, Hahner L et al. C-reactive protein causes downregulation of vascular angiotensin subtype 2 receptors and systolic hypertension in mice. Circulation 2007; 115: 1020-1028.
30. Teoh H, Quan A, Lovren F, Wang G, Tirgari S, Szmitko PE, et al., Ward ME Impaired endothelial function in creative protein overexpressing mice. Atherosclerosis 2008; 201: 318-325.
31. Mann JJ, Payne JR, Shah T, Pennell DJ, Humphries SE, Montgomery HE. C-reactive protein gene variant and the human left ventricular growth response to exercise: data from the LARGE heart study. J Cardiovasc Pharmacol TM 2010; 55: 26-29